Pfizer
The antiviral medication was found to interact with over 2,000 prescription drugs.
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.
PointClickCare's senior health-focused datasets will help to influence Pfizer's decisions on new therapies.
Also, a new research centre at the University of Melbourne will use AI to advance breast cancer screening.
The solution uses gamification to increase patient adherence.
The proposed acquisition and research partnership will add to the biopharmaceutical giant's growing digital capabilities and bolster its efforts "to pave a new era for digital health".
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund, Teva Pharmaceuticals, and Amazon Web Services, is currently accepting applicants for its new challenge.
The partners will first focus on the German market.
ThoughtFull is giving free three-month access to counsellor or psychologist support via its mobile app.